The long-term follow-up of patients with endoscopically diagnosed reflux oesophagitis with specific emphasis to complaints

被引:6
|
作者
Loffeld, Susan M. L. A. [2 ]
Dackus, Gwen M. H. E. [2 ]
Loffeld, Ruud J. L. F. [1 ]
机构
[1] Med Ctr, Dept Internal Med Zaans, Zaandam, Netherlands
[2] Univ Maastricht, Zaandam, Netherlands
关键词
gastroesophageal reflux disease; long-term treatment; proton pump inhibitor; reflux oesophagitis; treatment; RELAPSE; EFFICACY; THERAPY; DISEASE; SAFETY;
D O I
10.1097/MEG.0b013e32834b8d18
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction Patients with gastroesophageal reflux disease (GERD) need long-term treatment with acid-suppressive therapy. Data on long-term follow-up are very rare. For this reason, a study was performed to detect complaints many years after diagnosis. Patients and methods All patients diagnosed with reflux oesophagitis in the years 1998-2000 were included. In the summer of 2010, they received a questionnaire with four different lists of questions pertaining to reflux complaints and use of medication. Severity and frequency were scored on 5-point and 6-point Likert scales, respectively; the GerdQ, a symptom activity index, and the gastrointestinal symptom-rating scale were also used. Results Complaints were reported by 130 patients (63%); the majority of these, 115 (88%), used acid suppressive therapy. Only 78 patients were in clinical remission, with or without therapy. The respondents with complaints were divided into two groups. Group 1: all patients with reflux complaints using acid suppressive therapy. Group 2: all patients with complaints without medication. Patients in group 1 were significantly older at the time of the endoscopic diagnosis compared with patients of group 2, and patients in group 1 had a hiatal hernia more often (P < 0.001). There was no difference in the overall symptom or the frequency score per patient between both groups, with a mean of 5.97 versus 6.8 and 13.4 versus 13.8 respectively. However, heartburn, nausea, acid regurgitation, epigastric pain, dysphagia and nocturnal complaints showed a significantly higher prevalence in patients of group 2. Scores for specific complaints were significantly lower in group 2 and there was no difference between the GerdQ, the symptom activity index and the gastrointestinal symptom-rating scale. Conclusion Despite effective therapy, only 37% of the patients are in complete remission. However, the individual symptom score is rather low. Patients without medication more often have reflux complaints but lower severity scores. Patients who still had complaints and used medication had a hiatal hernia significantly more often. Eur J Gastroenterol Hepatol 23:1122-1126 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:1122 / 1126
页数:5
相关论文
共 50 条
  • [1] Long-term neurological follow-up of HIV-positive patients diagnosed with syphilis
    Muldoon, E. G.
    Mooka, B.
    Reidy, D.
    O'Dea, S.
    Clarke, S.
    Courtney, G.
    Lyons, F.
    Bergin, C.
    Mulcahy, F.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (09) : 676 - 678
  • [2] Long-term follow-up and development of diverticulitis in patients diagnosed with diverticulosis of the colon
    Loffeld, R. J. L. F.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2016, 31 (01) : 15 - 17
  • [3] Rituximab in the treatment of 38 patients with Pemphigus with long-term follow-up
    Currimbhoy, S.
    Zhu, V.
    Dominguez, A. R.
    Pandya, A. G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (06) : 1050 - 1052
  • [4] Long-Term Follow-Up of Patients with Hypoparathyroidism
    Mitchell, Deborah M.
    Regan, Susan
    Cooley, Michael R.
    Lauter, Kelly B.
    Vrla, Michael C.
    Becker, Carolyn B.
    Burnett-Bowie, Sherri-Ann M.
    Mannstadt, Michael
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4507 - 4514
  • [5] Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases
    Ichinose, Kunihiro
    Origuchi, Tomoki
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Kamachi, Makoto
    Arima, Kazuhiko
    Tamai, Mami
    Nakamura, Hideki
    Ida, Hiroaki
    Kawakami, Atsushi
    Eguchi, Katsumi
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (02) : 483 - 487
  • [6] A long-term follow-up of zonisamide monotherapy
    Fukushima, Katsuyuki
    Seino, Masakazu
    EPILEPSIA, 2006, 47 (11) : 1860 - 1864
  • [7] A long-term follow-up of botulinum toxin A in cervical dystonia
    Mohammadi, B.
    Buhr, N.
    Bigalke, H.
    Krampfl, K.
    Dengler, R.
    Kollewe, K.
    NEUROLOGICAL RESEARCH, 2009, 31 (05) : 463 - 466
  • [8] Long-term follow-up in patients with CCFDN syndrome
    Walter, Maggie C.
    Bernert, Guenther
    Zimmermann, Uta
    Muellner-Eidenboeck, Andrea
    Moser, Elisabeth
    Kalaydjieva, Luba
    Lochmueller, Hanns
    Mueller-Felber, Wolfgang
    NEUROLOGY, 2014, 83 (15) : 1337 - 1344
  • [9] Clinical profile and long-term follow-up of 32 patients with postoperative permanent hypoparathyroidism
    Lorente-Poch, Leyre
    Sancho, Juan J.
    Carballo, Leticia
    Sitges-Serra, Antonio
    GLAND SURGERY, 2017, 6 : S3 - S10
  • [10] Long-term follow-up evaluation for a canine model of gastroesophageal reflux disease
    B.P. Jacob
    G. Dakin
    C. Divino
    W. Kim
    M. Gagner
    Surgical Endoscopy And Other Interventional Techniques, 2003, 17 : 354 - 354